29 January 2025
Top hires for VC & PE portfolio companies Q4-2024
Search Highlights
Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.
This quarter’s successful placements include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Antibody-based therapies | US |
| CEO | Oncolytic viruses | UK |
| CEO | Oncology biotech | Spain |
| Chief Financial Officer | Nanotechnology diagnostics | Switzerland |
| Chief Innovation Officer | Connected medical devices | France |
| Chief R&D Officer | Gene-encoded drug discovery | UK |
| Chief Commercial Officer | Computational chemistry | UK |
| Chief Operating Officer | Outpatient services | Switzerland |
| VP, Research & Preclinical | Synthetic biology | UK |
| VP, Global Head of Sales | Omics platform | US |
| VP, Marketing | Men's health | UK |
| Global Head of Regulatory Affairs | Anticoagulant technologies | UK |
| Head of Global Distribution | Specialty pharma | France |
| Program Director | Pharma software solutions | Belgium |
| Managing Partner | Regulatory affairs consultancy | US |
| Partner | Healthcare strategic communications | UK |
| Chair | Cardiac devices | Israel |
| Board Director | Specialty ingredients | UK |
Newly opened projects include:
| Function | Focus area | Location |
|---|---|---|
| CEO | Exosome technologies | Italy |
| Chief Scientific Officer | tRNA platform | US |
| Chief Business Officer | 3D genome technologies | UK |
| Chief Scientific Officer | Protein degraders | Italy |
| Chief Development Officer | T-cell technologies | UK |
| SVP, Clinical Operations | Cell therapies | US |
| VP, Country General Manager | Contract Research Organization | Japan |
| VP, Pharma Partnerships | Digital diagnostics | UK |
| VP, Head of Early Discovery | Computational drug discovery | Denmark |
| Global Head Toxicology Services | Laboratory & consulting services | Germany |
| Head of Sales International | Medical lasers | Germany |
| Head of Regulatory | Small molecule inhibitors | US |
| Marketing & Business Development Lead | Biological & chemical sensors | France |
| Country General Manager | Patient services | UK |
| Board Director | Immunotherapies | Belgium |
| Director of Venture Creation | University commercialization arm | UK |
Related
-
Company News
LSX World Congress conference with Justine McIlroy, Client Partner
12 May 2023
-
Thought Leadership
Five Shifts to Digital Personalized Healthcare
10 May 2023
-
Company News
Digital Health UK CEO and Commercial Leaders Breakfast
28 March 2023
-
Press Releases
Coulter Partners places Vice President of Intellectual Property at Amphista Therapeutics
09 March 2023